https://www.moneycontrol.com/news/trends/health-trends/laurus-labs-receives-licence-from-drdo-to-manufacture-and-market-covid-drug-2dg-7118081.html
0
0
7/2/21 at 9:53am
Organization
Moneycontrol
45 words
0
Comments
2DG has been given emergency approval by the Drugs Controller General of India (DCGI) for use on COVID-19 patients in the country, Laurus Labs said in a regulatory filing.
You are the first to view
Create an account
or login to join the discussion